[Recent advancement in diagnosis and treatment of prostate cancer--general concepts].
Prostate cancers which are diagnosed during PSA screening include a significant number of clinically insignificant cancers. Useful strategy for needle biopsy is warranted. In addition, useful strategy for the timing of radical therapy for localized prostate cancer is warranted to be established. These strategies are essential to avoid over-diagnosis and over-treatment.
Akaza
Hideyuki
H
Department of Urology, Graduate University of Tsukuba.
D059002:Androgen Receptor Antagonists; D014408:Biomarkers, Tumor / Q000097:blood; D001707:Biopsy, Needle; D015195:Drug Design; D006801:Humans; D008297:Male; D008403:Mass Screening; D008991:Monitoring, Physiologic; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D011788:Quality of Life; D011944:Receptors, Androgen / Q000235:genetics; D013997:Time Factors
D059002:Androgen Receptor Antagonists; D014408:Biomarkers, Tumor; D011944:Receptors, Androgen; D017430:Prostate-Specific Antigen